Article info
PDFGestational Trophoblastic Neoplasia
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial
- Address correspondence and reprint requests to Benoit You, MD, PhD, Service d’Oncologie Médicale, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, F-69310. 165, chemin du grand Revoyet 69495 Pierre-Bénite, France. E-mail: benoit.you@chu-lyon.fr.
Citation
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial
Publication history
- Received May 1, 2015
- First published January 1, 2016.
Online issue publication
January 27, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2015 by IGCS and ESGO